Deprizine
Name: Deprizine
Precautions
This drug is not recommended for use in children when used to treat pathological hypersecretory conditions or to maintain healing of erosive esophagitis. In the treatment of other indications, safety and efficacy have not been established in patients younger than 1 month (prescription-only formulations) and 12 years (over-the-counter formulations).
Consult WARNINGS section for additional precautions.